Seizurogenic effects of low-dose naloxone in tramadol overdose

Iranian Journal of Pharmacology and Therapeutics

Volumn 11, Issue 1, 2012, Pages 6-9

  Farzaneh, Esmaeil ^a   Mostafazadeh, Babak ^b   Mehrpour, Omid ^c  

^a ARDABIL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c BIRJAND UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Naloxone; Seizure; Tramadol overdoses

Indexed keywords

NALOXONE; TRAMADOL;

ADOLESCENT; ADULT; AGITATION; APNEA; ARTICLE; COMA; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DRUG MECHANISM; DRUG OVERDOSE; EMERGENCY WARD; FEMALE; HUMAN; HYPERTENSION; INCIDENCE; IRAN; LETHARGY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NAUSEA; PAIN; PROGNOSIS; RESPIRATION DEPRESSION; RISK FACTOR; SEIZURE; SIDE EFFECT; SINGLE DRUG DOSE; TACHYCARDIA; TRAMADOL OVERDOSE; URINALYSIS;

EID: 84867911244     PISSN: 17352657     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Gold Standard, Inc. Tramadol. Clinical Pharmacology. Available at: http://www.clinicalpharmacology.com. Accessed on 12/16/2008
2. Brinker A, Bonnel RA, Beitz J. Abuse, dependence, or withdrawal associated with tramadol. Am J Psychiatr 2002; 159: 881.
3. Watson WA, Litovitz TL, Rodgers GC Jr, Klein-Schwartz W, Youniss J, Rose SR, et al. Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2003, 21:353-421.
4. Opioid intoxication in adult, management available at http://www.uptodate.com. Accessed 15 Jan 2010.
5. Reisine T, Pasternak GOpioid analgesics and antagonists. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gillman AG. Goodman and Gillman's the Pharmacological Basis of Therapeutics. 9th ed. NewYork: McGraw Hill Press, 1996; 521-555.
6. McNicholas LF, Martin WR. New and experimental therapeutic roles for naloxone and related opioid antagonists. Drugs 1984; 27:81-93.
7. Enteen L, Bauer J, McLean R, Wheeler E, Huriaux E, Kral AH, Bamberger JD. Overdose prevention and naloxone prescription for opioid users in San Francisco. J Urban Health 2010; 87:6.
8. Rehni AK, Singh I, Kumar M. Tramadol-induced seizurogenic effect: a possible role of opioid-dependent aminobutyric acid pathway. Basic Clin Pharmacol Toxicol 2008; 103:262-266.
9. Rehni AK, Singh TG, Singh N, Arora S. Tramadol-induced seizurogenic effect: a possible role of opioid-dependent histamine (H1) receptor activation-linked mechanism. Naunyn Schmiedebergs Arch Pharmacol 2009; 381:11-19.
10. Shadnia S, Soltaninejad K, Heydari K, Sasanian G, Abdollahi M. Tramadol intoxication: a review of 114 cases. Hum Exp Toxicol 2008; 27:201-205.
11. Yang L, Li F, Ge W, Mi C, Wang R, Sun R. Protective effects of naloxone in two-hit seizure model. Epilepsia 2010; 51:344-353.
12. van de Kamp JL. The effect of naloxone administration on pregnancy-associated seizures. Life Sci 1986; 38:1899-1905.
13. Omrani A, Ghadamia MR, Fathia N, Tahmasiana M, Fathollahib Y, Touhidi A. Naloxone improves impairment of spatial peformance induced by pentylentetrazol. Neuroscience 2007; 145:824-831.
14. Sansone RA, Sansone LA. Tramadol seizures, serotonin syndrome, and coadministered antidepressants. Psychiatry (Edgmont) 2009; 6:17-21.